BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34978886)

  • 21. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fluorescent dyes on in vitro-differentiated, late-stage Plasmodium falciparum gametocytes.
    Gebru T; Mordmüller B; Held J
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7398-404. PubMed ID: 25267675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage
    Wong HN; Padín-Irizarry V; van der Watt ME; Reader J; Liebenberg W; Wiesner L; Smith P; Eribez K; Winzeler EA; Kyle DE; Birkholtz LM; Coertzen D; Haynes RK
    Front Chem; 2019; 7():901. PubMed ID: 31998692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spiroindolone KAE609 for falciparum and vivax malaria.
    White NJ; Pukrittayakamee S; Phyo AP; Rueangweerayut R; Nosten F; Jittamala P; Jeeyapant A; Jain JP; Lefèvre G; Li R; Magnusson B; Diagana TT; Leong FJ
    N Engl J Med; 2014 Jul; 371(5):403-10. PubMed ID: 25075833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand.
    Putaporntip C; Kuamsab N; Kosuwin R; Tantiwattanasub W; Vejakama P; Sueblinvong T; Seethamchai S; Jongwutiwes S; Hughes AL
    Clin Microbiol Infect; 2016 Mar; 22(3):285.e1-8. PubMed ID: 26548510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.
    Thita T; Jadsri P; Thamkhantho J; Ruang-Areerate T; Suwandittakul N; Sitthichot N; Mahotorn K; Tan-Ariya P; Mungthin M
    Malar J; 2018 May; 17(1):197. PubMed ID: 29764451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viability Screen of LOPAC
    Tong JX; Ang SEL; Tan EHN; Tan KSW
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum
    de Carvalho LP; Sandri TL; José Tenório de Melo E; Fendel R; Kremsner PG; Mordmüller B; Held J
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.
    Schmitt EK; Ndayisaba G; Yeka A; Asante KP; Grobusch MP; Karita E; Mugerwa H; Asiimwe S; Oduro A; Fofana B; Doumbia S; Su G; Csermak Renner K; Venishetty VK; Sayyed S; Straimer J; Demin I; Barsainya S; Boulton C; Gandhi P
    Clin Infect Dis; 2022 May; 74(10):1831-1839. PubMed ID: 34410358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro dual activity of Aloe marlothii roots and its chemical constituents against Plasmodium falciparum asexual and sexual stage parasites.
    Mianda SM; Invernizzi L; van der Watt ME; Reader J; Moyo P; Birkholtz LM; Maharaj VJ
    J Ethnopharmacol; 2022 Oct; 297():115551. PubMed ID: 35850311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence and Spread of
    Kobasa T; Talundzic E; Sug-Aram R; Boondat P; Goldman IF; Lucchi NW; Dharmarak P; Sintasath D; Fukuda M; Whistler T; MacArthur J; Udhayakumar V; Prempree P; Chinanonwait N
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.
    Abdul-Ghani R; Beier JC
    Parasitol Res; 2014 Oct; 113(10):3535-46. PubMed ID: 25185662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.
    Ariey F; Witkowski B; Amaratunga C; Beghain J; Langlois AC; Khim N; Kim S; Duru V; Bouchier C; Ma L; Lim P; Leang R; Duong S; Sreng S; Suon S; Chuor CM; Bout DM; Ménard S; Rogers WO; Genton B; Fandeur T; Miotto O; Ringwald P; Le Bras J; Berry A; Barale JC; Fairhurst RM; Benoit-Vical F; Mercereau-Puijalon O; Ménard D
    Nature; 2014 Jan; 505(7481):50-5. PubMed ID: 24352242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.